TECHNOLOGY
MITT
Macromolecule Intracellular Transduction Technology
HUBISLAB unique technology adapts skin biology theory and clinical testingthrough MITT (Macromolecule Intracellular Transduction Technology), our products are designed to deliverhelpful ingredients deep into the skin and maximize their effects.
Macromolecular Transduction Domain
- MITT : Macromolecule Intracellular Transduction Technology
- MTD : Macromolecule Transduction Domain
- Cargo : Therapeutic macromolecular substance
Therapeutic macromolecular material
- Therapeutic antibodies
- Recombinant proteins
- Peptides
- siRNA or DNA
- Chemicals
- (Nanoparticles
Innovation
Protein, nucleic acids, peptides, and other compounds that were difficult to transmit can now be transferred into target cells Business
Effectiveness
Products created as a result of the new technology results in greater beneficial effects than ever before
Business
Value A combined market fordifferent product fields, i.e. new drugsand functional cosmetics, can be reached
MITT SKIN PENETRATION
ORDINARY GROWTH FACTOR
